Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Seres Therapeutics Inc (NASDAQ: MCRB) closed at $0.85 in the last session, up 1.35% from day before closing price of $0.84. In other words, the price has increased by $1.35 from its previous closing price. On the day, 2.12 million shares were traded. MCRB stock price reached its highest trading level at $0.8645 during the session, while it also had its lowest trading level at $0.83.
Ratios:
We take a closer look at MCRB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.89 and its Current Ratio is at 1.38.
On April 21, 2023, JP Morgan started tracking the stock assigning a Neutral rating and target price of $7.
Goldman Downgraded its Neutral to Sell on July 23, 2021, whereas the target price for the stock was revised from $24 to $7.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 16 ’24 when DesRosier Thomas sold 873 shares for $0.84 per share. The transaction valued at 733 led to the insider holds 124,173 shares of the business.
von Moltke Lisa sold 973 shares of MCRB for $817 on Aug 16 ’24. The insider now owns 21,013 shares after completing the transaction at $0.84 per share. On Aug 16 ’24, another insider, Henn Matthew R., who serves as the insider of the company, sold 923 shares for $0.84 each. As a result, the insider received 775 and left with 67,247 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MCRB now has a Market Capitalization of 144414704 and an Enterprise Value of 270136736. For the stock, the TTM Price-to-Sale (P/S) ratio is 390.31. Its current Enterprise Value per Revenue stands at 722.291 whereas that against EBITDA is -1.782.
Stock Price History:
Over the past 52 weeks, MCRB has reached a high of $2.11, while it has fallen to a 52-week low of $0.54. The 50-Day Moving Average of the stock is -14.42%, while the 200-Day Moving Average is calculated to be -13.94%.
Shares Statistics:
According to the various share statistics, MCRB traded on average about 4.42M shares per day over the past 3-months and 6832030 shares per day over the past 10 days. A total of 135.04M shares are outstanding, with a floating share count of 118.98M. Insiders hold about 20.79% of the company’s shares, while institutions hold 27.01% stake in the company. Shares short for MCRB as of 1726185600 were 17215115 with a Short Ratio of 3.89, compared to 1723680000 on 16754683. Therefore, it implies a Short% of Shares Outstanding of 17215115 and a Short% of Float of 15.76.
Earnings Estimates
Its stock is currently analyzed by 5.0 different market analysts. The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.12 and low estimates of -$0.27.
Analysts are recommending an EPS of between -$0.87 and -$1.06 for the fiscal current year, implying an average EPS of -$0.97. EPS for the following year is -$0.6, with 6.0 analysts recommending between -$0.16 and -$0.88.
